This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Yutaka Waki: Innovator in Movement Disorder Treatments
Introduction
Yutaka Waki is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of movement disorders such as Parkinson's disease. With a total of 2 patents, Waki's work focuses on innovative methods to improve patient outcomes.
Latest Patents
Waki's latest patents include groundbreaking methods for treating movement disorders by administering effective amounts of one or more adenosine A receptor antagonists to patients in need. His inventions aim to decrease the adverse effects of L-DOPA therapy in Parkinson's disease patients. Additionally, he has developed methods for treating patients with sub-clinically effective doses of L-DOPA, combining it with adenosine A receptor antagonists to achieve a L-DOPA sparing effect. His patents also explore co-administration strategies involving dopamine agonists, COMT inhibitors, and MAO inhibitors to prolong effective treatment and delay the onset of L-DOPA motor complications.
Career Highlights
Waki is currently associated with Kyowa Hakko Kirin Co., Limited, where he continues to advance research in the field of movement disorders. His work has garnered attention for its potential to transform treatment protocols and improve the quality of life for patients suffering from these conditions.
Collaborations
Waki collaborates with esteemed colleagues such as Hiroshi Kase and Akihisa Mori, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yutaka Waki's contributions to the treatment of movement disorders highlight his role as a leading inventor in the medical field. His innovative approaches and collaborative efforts continue to pave the way for advancements in patient care.